Friday, 03. September 2010

Life sciences


Advanced genomics and its applications for health



Combating major diseases



Specific support actions across thematic priority 1


Policy support

International co-operation

Reporting module


MOLTOOLS - Advanced molecular tools for array-based analyses of genomes, transcriptomes, proteomes, and cells (Life sciences, genomics and biotechnology for health) (2004-01-01 - 2007-06-30) (»add to infobox)



ACRONYM:MOLTOOLS
BUDGET:11.873.000 €
FUNDING:8.408.460 €
INSTRUMENT:Integrated Project
PROGRAMME:Life sciences, genomics and biotechnology for health
The recording of complete genome sequences provides for the first time opportunities to comprehensively characterize the flow of information from genetic variation at the DNA level, over messages expressed as RNA, and on to their protein products, and to functions of the cell. By eavesdropping on these processes it will be possible to identify genetic variation underlying malignancy, diabetes, and other common deseases, and to monitor and ultimately explain molecular processes involved in these and other important conditions. Recent years have seen rapid growth of techniques for high-throughput analyses of genes, transcripts, proteins,and cells using microarrays, but current methods still capture only a small fraction of the information embodied in the molecules. This project brings together leading European laboratories, and one US lab.The purpose is to build an infrastructure to develop a next-generation toolbox for large-scale molecular analyses in the following six interrelated analytical modes: 1)parts of whole genomes will be rapidly scanned for any alterations; 2)extensive sets of genetic variants will be traced in large numbers of individuals; 3)patterns of gene expression will be recorded at unprecedented quantitative and sequence resolution; 4)expression and interactions of large sets of proteins will be measured in array formats; 5)novel molecular tools will enable analyses at the ultimate level of single DNA, RNA, or protein molecules;and 6)arrays of viable cells will permit extensive functional analyses to characterise complex processes in high throughput. The suite of microarray-based technologies developed in the course of this program will be of strategic value throughout biological research and for the biotech and pharmaceutical industries. Gradually the techniques will also become available in clinical medicine to guide diagnosis and therapy; and in agriculture and environmental monitoring.

COORDINATOR (1/1) 


Ulf LANDEGREN (Contact / UPPSALA UNIVERSITET (SE021 - Uppsala län) (SE - Sweden))

PARTICIPANTS (14/14) 


Anthony BROOKES (Contact / KAROLINSKA INSTITUTET (SE010 - Stockholms län) (SE - Sweden))

Dolores J. CAHILL (Contact / ROYAL COLLEGE OF SURGEONS IN IRELAND (IE021 - Dublin) (IE - Ireland))

N. N. (Contact / CONSORTIUM NATIONAL DE RECHERCHE EN GENOMIQUE (FR104 - Essonne) (FR - France))

Joerg HOHEISEL (Contact / DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG (DE125 - Heidelberg, Stadtkreis) (DE - Germany))

Olli KALLIONIEMI (Contact / VALTION TEKNILLINEN TUTKIMUSKESKUS (VTT) (FI181 - Uusimaa) (FI - Finland))

Jorn KOCH (Contact / AARHUS UNIVERSITET (DK00D - Århus amt) (DK - Denmark))

Silke SPERLING (Contact / MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV (DE212 - München, Kreisfreie Stadt) (DE - Germany))

Andres METSPALU (Contact / EESTI BIOCENTRE - ESTONIAN BIOCENTRE (EE008 - Lõuna-Eesti) (EE - Estonia))

Ryan EGELAND (Contact / OXFORD GENE TECHNOLOGY (OPERATIONS) LTD (UKJ14 - Oxfordshire) (UK - Great Britain))

Michael John TAUSSIG (Contact / THE BABRAHAM INSTITUTE (UKH12 - Cambridgeshire CC) (UK - Great Britain))

Marc ZABEAU (Contact / METHEXIS GENOMICS NV (BE234 - Arr. Gent) (BE - Belgium))

Michael DAHMS (Contact / FEBIT AG (DE126 - Mannheim, Stadtkreis) (DE - Germany))

Arvydas JANULAITIS (Contact / FERMENTAS UAB (LT00A - Vilniaus apskritis) (LT - Lithuania))

David BERGMAN (Contact / AMIC AB (SE021 - Uppsala län) (SE - Sweden))

RELATED THEMATIC AREAS (1/1) 

Gene expression and proteomics




SEARCH



»Advanced Search



SHORT CUTS

»Thematic areas

»Organisations

»Persons



LAST PAGES (3/100) show all
»
Person: Cecilia HOLM
»
Thematic area: Rational and accelerated development of new, safer, more effective drugs
»
Person: Jiri STULIK


INFOBOX (0/0) show all
Your infobox is empty


LifeCompetence is operated by AVEDAS.
LifeCompetence operated by AVEDAS
Contact: support@avedas.com


STOCKHOLM-UPPSALA LIFE SCIENCE
Powered by CONVERIS 2.0